F. Jacob Huff

2.6k total citations
55 papers, 2.0k citations indexed

About

F. Jacob Huff is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, F. Jacob Huff has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 17 papers in Physiology and 14 papers in Pharmacology. Recurrent topics in F. Jacob Huff's work include Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (15 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). F. Jacob Huff is often cited by papers focused on Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (15 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). F. Jacob Huff collaborates with scholars based in United States, United Kingdom and Finland. F. Jacob Huff's co-authors include John H. Growdon, Suzanne Corkin, Steven H. Belle, Robert D. Nebes, Christopher B. Brady, Joseph Francis, Jack Protetch, David C. Martin, T. John Rosen and Lewis H. Kuller and has published in prestigious journals such as Gastroenterology, American Journal of Psychiatry and Neurology.

In The Last Decade

F. Jacob Huff

55 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Jacob Huff United States 23 959 772 555 234 213 55 2.0k
Sophie Auriacombe France 33 1.2k 1.3× 690 0.9× 672 1.2× 191 0.8× 503 2.4× 62 2.7k
Michael Fisman Canada 15 1.3k 1.4× 830 1.1× 983 1.8× 228 1.0× 207 1.0× 31 2.7k
David Bachman United States 29 1.3k 1.3× 692 0.9× 993 1.8× 251 1.1× 266 1.2× 68 3.4k
Jordi Peña‐Casanova Spain 33 1.4k 1.5× 1.0k 1.3× 519 0.9× 200 0.9× 204 1.0× 114 3.0k
Asenath La Rue United States 30 1.5k 1.6× 588 0.8× 1.2k 2.1× 140 0.6× 131 0.6× 68 3.1k
Márcia Radanovic Brazil 33 1.6k 1.7× 779 1.0× 872 1.6× 245 1.0× 254 1.2× 116 3.2k
William G. Snow Canada 22 1.2k 1.3× 631 0.8× 696 1.3× 79 0.3× 369 1.7× 49 2.6k
Armin Scheurich Germany 30 881 0.9× 1.1k 1.4× 794 1.4× 77 0.3× 188 0.9× 56 2.7k
Jin Hyeong Jhoo South Korea 29 1.5k 1.6× 635 0.8× 850 1.5× 162 0.7× 154 0.7× 100 3.1k
Satoshi Tanimukai Japan 25 1.0k 1.1× 516 0.7× 856 1.5× 106 0.5× 486 2.3× 55 2.0k

Countries citing papers authored by F. Jacob Huff

Since Specialization
Citations

This map shows the geographic impact of F. Jacob Huff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Jacob Huff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Jacob Huff more than expected).

Fields of papers citing papers by F. Jacob Huff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Jacob Huff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Jacob Huff. The network helps show where F. Jacob Huff may publish in the future.

Co-authorship network of co-authors of F. Jacob Huff

This figure shows the co-authorship network connecting the top 25 collaborators of F. Jacob Huff. A scholar is included among the top collaborators of F. Jacob Huff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Jacob Huff. F. Jacob Huff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vakil, Nimish, F. Jacob Huff, & K C Cundy. (2013). Randomised clinical trial: arbaclofen placarbil in gastro‐oesophageal reflux disease – insights into study design for transient lower sphincter relaxation inhibitors. Alimentary Pharmacology & Therapeutics. 38(2). 107–117. 20 indexed citations
2.
Nance, Patricia W., et al.. (2011). Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injury. Spinal Cord. 49(9). 974–980. 7 indexed citations
3.
Lal, Rattan, et al.. (2010). The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil. International Journal of Clinical Pharmacology and Therapeutics. 48(2). 120–128. 17 indexed citations
4.
Carragee, Eugene J., Jack A. Klapper, Michael K. Schaufele, et al.. (2006). 7:423. Oral REN-1654 in Sciatica: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study in Subjects With Pain Due to Lumbosacral Radiculopathy. The Spine Journal. 6(5). 2S–2S. 3 indexed citations
5.
Chubb, Charles, et al.. (2003). Visual identification and spatial location in Alzheimer’s disease. Brain and Cognition. 52(2). 155–166. 21 indexed citations
6.
Huff, F. Jacob. (1996). Preliminary Evaluation of Besipirdine for the Treatment of Alzheimer's Diseasea. Annals of the New York Academy of Sciences. 777(1). 410–414. 11 indexed citations
7.
Huff, F. Jacob, Neal R. Cutler, Frank P. Zemlan, et al.. (1996). A Treatment and Withdrawal Trial of Besipirdine in Alzheimer Disease. Alzheimer Disease & Associated Disorders. 10(2). 93–102. 10 indexed citations
8.
Sramek, John J., et al.. (1995). A “bridging” (safety/tolerance) study of Besipirdine Hydrochloride in patients with Alzheimer's disease. Life Sciences. 57(12). 1241–1248. 6 indexed citations
9.
Ganguli, Mary, Steven H. Belle, G. Ratcliff, et al.. (1993). Sensitivity and Specificity for Dementia of Population-Based Criteria for Cognitive Impairment: The MoVIES Project. Journal of Gerontology. 48(4). M152–M161. 137 indexed citations
10.
Murphy, Michael, et al.. (1991). Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's Diseasea. Annals of the New York Academy of Sciences. 640(1). 253–262. 37 indexed citations
11.
López, Oscar L., Bruce S. Rabin, & F. Jacob Huff. (1991). Serum auto-antibodies in Alzheimer's disease. Acta Neurologica Scandinavica. 84(5). 441–444. 17 indexed citations
12.
Huff, F. Jacob, et al.. (1991). Potential Clinical Use of an Adrenergic/Cholinergic Agent (HP 128) in the Treatment of Alzheimer's Disease. Annals of the New York Academy of Sciences. 640(1). 263–267. 3 indexed citations
13.
Zubenko, George S., et al.. (1990). Brain Imaging Abnormalities in Mental Disorders of Late Life. Archives of Neurology. 47(10). 1107–1111. 121 indexed citations
14.
Ganguli, Mary, et al.. (1990). Serial Sevens Versus World Backwards: A Comparison of the Two Measures of Attention From the MMSE. Journal of Geriatric Psychiatry and Neurology. 3(4). 203–207. 52 indexed citations
15.
Kuller, Lewis H., et al.. (1990). The University of Pittsburgh Alzheimer’s Disease Patient Registry: The Monongahela Valley Independent Elders Survey (MoVIES). Aging Clinical and Experimental Research. 2(3). 302–305. 14 indexed citations
16.
Huff, F. Jacob, et al.. (1989). Activities and Kinetic Properties of Lumbar Cerebrospinal Fluid Cholinesterases in Relation to Clinical Diagnosis, Severity, and Progression of Alzheimer's Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 16(4). 406–410. 6 indexed citations
17.
López, Oscar L., F. Jacob Huff, A. Julio Martinez, & Carlos D. Bedetti. (1989). Prevalence of thyroid abnormalities is not increased in Alzheimer's disease. Neurobiology of Aging. 10(3). 247–251. 17 indexed citations
18.
Huff, F. Jacob, et al.. (1988). No effect of haloperidol on cerebrospinal fluid acetylcholinesterase in patients with schizophrenia. Biological Psychiatry. 24(6). 701–704. 7 indexed citations
19.
Huff, F. Jacob, et al.. (1988). A comparison of lexical-semantic impairments in left hemisphere stroke and Alzheimer's disease. Brain and Language. 34(2). 262–278. 74 indexed citations
20.
Zubenko, George S., et al.. (1988). Cognitive function and platelet membrane fluidity in Alzheimer's disease. Biological Psychiatry. 24(8). 925–936. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Auriacombe Breakdown of academic impact, for papers by Michael Fisman Breakdown of academic impact, for papers by David Bachman Breakdown of academic impact, for papers by Jordi Peña‐Casanova Breakdown of academic impact, for papers by Asenath La Rue Breakdown of academic impact, for papers by Márcia Radanovic Breakdown of academic impact, for papers by William G. Snow Breakdown of academic impact, for papers by Armin Scheurich Breakdown of academic impact, for papers by Jin Hyeong Jhoo Breakdown of academic impact, for papers by Satoshi Tanimukai
Rankless by CCL
2026